LeeAnn Shiveley Selected Research

Nucleosides

1/2008

Multiple-dose pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in patients with HIV-1 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

LeeAnn Shiveley Research Topics

Disease

2	Infections 01/2008 - 01/2006
1	HIV Infections (HIV Infection) 06/2006

Drug/Important Bio-Agent (IBA)

3	apricitabineIBA 01/2008 - 01/2006
2	DeoxycytidineIBA 01/2008 - 01/2006
2	Reverse Transcriptase InhibitorsIBA 01/2008 - 01/2006
1	NucleosidesIBA 01/2008
1	RNA (Ribonucleic Acid)IBA 06/2006

Therapy/Procedure

1	Therapeutics 06/2006